Showing results (461-470 of 484) with videos related to

Sort By:
Pageof 49
Annals of Surgical Oncology|August 8, 2021
Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast CancerKelly M Herremans, Morgan P Cribbin, Andrea N Riner, et al.
NPJ Digital Medicine|November 29, 2025
Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillanceIngrid Luo, Anna Graber-Naidich, Mengrui Zhang, et al.
Cancer Discovery|September 14, 2017
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingAadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, et al.
JCO Precision Oncology|February 9, 2022
EGFR Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an EGFR Tyrosine Kinase InhibitorJonathan W Goldman, Chris Karlovich, Lecia V Sequist, et al.
Nature Cancer|September 10, 2021
Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung CancerEverett J Moding, Yufei Liu, Barzin Y Nabet, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
A Phase 2 Single-Arm Trial of High-Dose Precision Targeted Radiation Therapy Added to Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerMichael F Gensheimer, Nikhil V Kotha, Lucas K Vitzthum, et al.
The New England Journal of Medicine|April 30, 2015
Rociletinib in EGFR-mutated non-small-cell lung cancerLecia V Sequist, Jean-Charles Soria, Jonathan W Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2025
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2Pascale Tomasini, Yongsheng Wang, Yongsheng Li, et al.
Cancer Discovery|October 19, 2020
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase InhibitionMichael S Binkley, Young-Jun Jeon, Monica Nesselbush, et al.
Cell|October 2, 2020
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y Nabet, Mohammad S Esfahani, Everett J Moding, et al.
Pageof 49